Market Place
Sourcing Support
FDA updates label of 33-year-old cancer drug with dose & warning
21 Nov 2024 //
ENDPTS
FDA Updates Label Of 33-Year-Old Cancer Drug With Warning
20 Nov 2024 //
ENDPTS
Nkarta`s cell therapy needs specific pre-conditioning
27 Jun 2023 //
FIERCE BIOTECH
CRISPR Therapeutics` CAR-T Cancer Therapy Shows Early Promise
13 Oct 2021 //
BIOSPACE
Enforcement Report - Week of September 1, 2021
01 Sep 2021 //
FDA
CBMG` Novel CD19/CD20 Bi-specific CAR-T Cell Product Shows Promising Results
10 Jun 2021 //
PRNEWSWIRE
CBMG` Novel Anti-CD20 CAR-T Cell Therapy Shows Promising Safety and Efficacy
10 Jun 2021 //
PRNEWSWIRE
Imbruvica®?(ibrutinib) Combination Therapy Data From Two Studies
09 Dec 2019 //
BUSINESSWIRE
Unum Plunges After FDA Places Another Clinical Hold on Company Asset
04 Jul 2019 //
BIOSPACE
JIANGSU YEW Pharmaceutical Co. Ltd. Fails EDQM Inspection
15 Sep 2018 //
EDQM
Juno notches positive data for second-chance CAR-T JCAR017
05 Jun 2017 //
FIERCE BIOTECH
Actavis LLc Generic Fludarabine Phosphate Receives Approval In US
02 Mar 2017 //
FDA
EU Commission Grants Marketing Authorization for Arzerra
12 Dec 2016 //
GLOBENEWSWIRE
Juno Deaths: Toxicity is Therapy Specific, Not Risk to Whole CAR-T Field
01 Dec 2016 //
IN PHARMATECHNOLOGIST
Does a Trump Presidency Mean Changes for Pharma Advertising?
29 Nov 2016 //
FIERCE PHARMA
Adaptimmune stock slides after poor efficacy forces it to add fludarabine
12 Oct 2016 //
FIERCE BIOTECH
Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection
19 Sep 2016 //
EDQM
TaiGen initiates clinical trial of leukemia drug in China
04 May 2015 //
BIOSPECTRUM ASIA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.